Estimating the predictive value of negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) results: A prospective study.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 11 12 2020
medline: 14 10 2021
entrez: 10 12 2020
Statut: ppublish

Résumé

We performed a prospective study of 501 patients, regardless of symptoms, admitted to the hospital, to estimate the predictive value of a negative nasopharyngeal swab for severe acute respiratory coronavirus virus 2 (SARS-CoV-2). At a positivity rate of 10.2%, the estimated negative predictive value (NPV) was 97.2% and the NPV rose as prevalence decreased during the study.

Identifiants

pubmed: 33298203
pii: S0899823X20013628
doi: 10.1017/ice.2020.1362
pmc: PMC7783084
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1257-1259

Subventions

Organisme : NLM NIH HHS
ID : R01 LM012836
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG064191
Pays : United States

Auteurs

David Hirschwerk (D)

Division of Infectious Diseases, Department of Medicine, North Shore University Hospital, Manhasset and Long Island Jewish Medical Center, New Hyde Park, New York.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Mathew Foley (M)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Department of Emergency Medicine, North Shore University Hospital, Manhasset, New York.

Martin Lesser (M)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.

Bruce Farber (B)

Division of Infectious Diseases, Department of Medicine, North Shore University Hospital, Manhasset and Long Island Jewish Medical Center, New Hyde Park, New York.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

James M Crawford (JM)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Karina W Davidson (KW)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.

Gregory J Berry (GJ)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Infectious Disease Diagnostics, Northwell Health Laboratories, Little Neck, New York.

Elizabeth Smith (E)

Infectious Disease Diagnostics, Northwell Health Laboratories, Little Neck, New York.

Charles Kast (C)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Department of Medicine, North Shore University Hospital, Manhasset, New York.

Vladimir Volel (V)

Department of Medicine, North Shore University Hospital, Manhasset, New York.

Thomas McGinn (T)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH